This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richard G. Fiscella, MPH
Chicago, Ill

Arch Ophthalmol. 1993;111(6):730.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—I read with great interest the article on the toxicity of intravitreous ceftazidime in primate retina by Campochiaro and Green.¹ I agree that vancomycin and ceftazidime would be an excellent combination of antibiotics for the empiric treatment of endophthalmitis from the standpoint of antibacterial spectrum and lack of retinal toxic effects. However, one important consideration that is often overlooked or inadequately studied is the physical incompatibility of various antibacterial agents as well as antiinflammatory agents in combination or even injected one after the other.

Ceftazidime (4 mg/0.1 mL) was reported to form an "instantaneous" precipitate when added to a burette that previously contained vancomycin at a concentration of 1 mg/0.1 mL.² Vancomycin may precipitate because of an alkaline pH due to the presence of sodium carbonate in the ceftazidime formulation.² However, the manufacturer of Ceptaz (Glaxo, Research Triangle Park, NC) also mentions precipitation . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?